Manulife (Manufacturers Life Insurance)’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-37,665
Closed -$1.04M 3294
2021
Q2
$1.04M Sell
37,665
-619
-2% -$12.2K ﹤0.01% 1974
2021
Q1
$631K Sell
38,284
-2,258
-6% -$51.4K ﹤0.01% 2153
2020
Q4
$747K Buy
40,542
+1,964
+5% +$35.1K ﹤0.01% 1985
2020
Q3
$525K Buy
38,578
+8,339
+28% +$129K ﹤0.01% 1976
2020
Q2
$568K Buy
30,239
+7,419
+33% +$112K ﹤0.01% 1893
2020
Q1
$228K Buy
22,820
+4,171
+22% +$34.2K ﹤0.01% 2244
2019
Q4
$152K Sell
18,649
-618
-3% -$5.7K ﹤0.01% 2688
2019
Q3
$194K Buy
19,267
+146
+0.8% +$1.38K ﹤0.01% 2607
2019
Q2
$241K Buy
19,121
+7,723
+68% +$81.4K ﹤0.01% 2508
2019
Q1
$116K Buy
+11,398
New +$87.4K ﹤0.01% 2560

Manulife (Manufacturers Life Insurance)'s TBIO Position: Q3 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 37,665 shares — an estimated $1.04M sold.

Manulife (Manufacturers Life Insurance) first reported a position in TBIO in Q1 2019 and held it in 10 quarters. The position peaked at $1.04M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 37,665 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.04M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Translate Bio, Inc. Common Stock position peaked at $1.04M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.